THE GROVE MEDICAL GROUP
1 THE GROVE, GOSFORTH, NEWCASTLE UPON TYNECKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 265 | 317 | 83.6% | |
CKD 4 | 2008 | 380 | 446 | 85.2% | |
CKD 5 | 2009 | 24 | 24 | 100.0% | |
CKD 5 | 2010 | 31 | 34 | 91.2% | |
CKD 5 | 2011 | 36 | 38 | 94.7% | |
CKD 5 | 2012 | 37 | 41 | 90.2% | |
CKD 5 | 2013 | 40 | 46 | 87.0% | |
CKD003 | 2014 | 31 | 38 | 81.6% | |
CKD003 | 2015 | 33 | 39 | 84.6% | |
NM84 | 2016 | 32 | 43 | 74.4% | |
NM84 | 2017 | 26 | 43 | 60.5% | |
NM84 | 2018 | 23 | 38 | 60.5% | |
NM84 | 2020 | 17 | 30 | 56.7% | |
NM84 | 2022 | 23 | 34 | 67.6% | |
NM84 | 2023 | 33 | 45 | 73.3% |